Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - fluconazole, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - fluconazole-baxter intravenous infusion should be used only when fluconazole cannot be administered orally: 1. treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note: data suggest that the clinical efficacy of fluconazole is lower than that of amphotericin b in the treatment of the acute phase of cryptococcal meningitis. 2. maintenance therapy to prevent relapse of cryptococcal meningitis in patients with acquired immune deficiency syndrome (aids). 3. treatment of oropharyngeal and oesophageal candidiasis in patients with aids and other immunosuppressed patients. 4. secondary prophylaxis of oropharyngeal candidiasis in patients with human immunodeficiency virus (hiv) infection. 5. vaginal candidiasis, when topical therapy has failed. 6. serious and life-threatening candida infections in patients who are unable to tolerate amphotericin b. note: it remains to be shown that fluconazole is as effective as amphotericin b in the treatment of serious and life-threatening candida infections. until such data are available, amphotericin b remains the drug of choice.

Израел - Енглески - Ministry of Health

david margalit & co.ltd - fluconazole - solution for infusion - fluconazole 200 mg / 100 ml - fluconazole - fluconazole is indicated in the following fungal infections.fluconazole is indicated in adults for the treatment of:• cryptococcal meningitis.• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene topical treatment are insufficient.fluconazole is indicated in adults for the prophylaxis of:• relapse of cryptococcal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving haematopoetic stem cell transplantation).fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.consideration should be given to official guidance on the appropriate use of antifungals.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - fluconazole -

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

bayer new zealand limited - fluconazole 150mg; clotrimazole 10 mg/g; clotrimazole 10 mg/g; fluconazole 150mg - combination - active: fluconazole 150mg clotrimazole 10 mg/g excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 10 mg/g excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: fluconazole 150mg - canesten fluconazole capsule & clotrimazole cream duo is indicated for vaginal candidiasis. the cream can also be used for relief of external itching/irritation and the management candida vulvovaginitis or infection of the peri-anal area.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - fluconazole 2 mg/ml (polymorph form iii) - solution for infusion - 2 mg/ml - active: fluconazole 2 mg/ml (polymorph form iii) excipient: sodium chloride water for injection - · cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary, cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole injection usp can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 mg/ml - fluconazole

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare limited - fluconazole - capsules hard - 50 milligram - fluconazole

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare limited - fluconazole - capsules hard - 150 milligram - fluconazole

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare limited - fluconazole - capsules hard - 200 milligram - fluconazole

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

gedeon richter plc - fluconazole - capsules hard - 150 milligram - fluconazole